That gap is costly. Late detection limits treatment options, increases complexity, and drives healthcare spending. The next leap in care won’t come from more scans; it will come from better signal: higher sensitivity, clearer resolution, and earlier insight into what’s changing inside the body.
Quantum sensing offers exactly that. By using quantum effects to measure extremely small changes in magnetic or electric fields, quantum sensors can push imaging beyond today’s limits, potentially revealing biological processes at the molecular or cellular level. And because some quantum sensors can operate at room temperature, they’re becoming increasingly practical for real clinical environments.
Case: Medical imaging enhancement with quantum sensing
Quantum sensors, including nitrogen-vacancy (NV) centers in diamonds, can detect tiny magnetic signals with exceptional precision. In medical imaging, this can translate into:
- Higher sensitivity MRI (detecting weaker signals, improving contrast, reducing scan time)
- Earlier detection of subtle abnormalities associated with cancer or neurodegenerative disease
- Better monitoring of treatment response over time with more precise measurement
- New diagnostic frontiers such as imaging at molecular scale in research and specialised clinical applications
The result: imaging that moves from “confirming disease” to detecting disease earlier and tracking it more intelligently.
Business value
- Earlier detection
Catching disease at more treatable stages improves outcomes and reduces downstream costs.
- Better diagnosis and monitoring
Higher precision supports more accurate clinical decisions and therapy adjustment.
- Operational efficiency
Improved sensitivity can reduce repeat scans and limit the need for invasive diagnostic procedures.
- New revenue streams
Advanced imaging capabilities enable specialised services and research partnerships in high-value care areas.
Technology readiness
Quantum-enhanced imaging is moving from research into early commercial products and clinical prototypes. Several systems and sensor technologies are being tested in controlled clinical trial settings, with adoption expected to increase as sensor costs fall and clinical integration improves.
The gating factors are familiar in healthcare innovation: regulatory approvals, device validation, workflow integration, and clinical evidence. As these pathways mature, quantum sensing is positioned to become a practical advantage first in specialised centres, then more broadly as devices scale.
Leading players and experiments
Qnami, GE Healthcare, Siemens Healthineers, NVision Imaging, Magritek, University of Oxford, and Harvard Medical School.
Discover more use cases here.
